[go: up one dir, main page]

DK1093369T3 - Middel med antidepressiv virkning indeholdende pramipexol og sertralin - Google Patents

Middel med antidepressiv virkning indeholdende pramipexol og sertralin

Info

Publication number
DK1093369T3
DK1093369T3 DK99934560T DK99934560T DK1093369T3 DK 1093369 T3 DK1093369 T3 DK 1093369T3 DK 99934560 T DK99934560 T DK 99934560T DK 99934560 T DK99934560 T DK 99934560T DK 1093369 T3 DK1093369 T3 DK 1093369T3
Authority
DK
Denmark
Prior art keywords
sertraline
containing pramipexole
antidepressant containing
antidepressant
pramipexole
Prior art date
Application number
DK99934560T
Other languages
Danish (da)
English (en)
Inventor
Jerzy Maj
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1093369T3 publication Critical patent/DK1093369T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99934560T 1998-07-07 1999-07-02 Middel med antidepressiv virkning indeholdende pramipexol og sertralin DK1093369T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (fr) 1998-07-07 1999-07-02 Agent a effet antidepressif

Publications (1)

Publication Number Publication Date
DK1093369T3 true DK1093369T3 (da) 2002-12-16

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99934560T DK1093369T3 (da) 1998-07-07 1999-07-02 Middel med antidepressiv virkning indeholdende pramipexol og sertralin

Country Status (32)

Country Link
US (1) US6255329B1 (fr)
EP (1) EP1093369B1 (fr)
JP (1) JP2002520273A (fr)
KR (1) KR100557692B1 (fr)
CN (1) CN1230168C (fr)
AR (1) AR019896A1 (fr)
AT (1) ATE228365T1 (fr)
AU (1) AU762128B2 (fr)
BG (1) BG64972B1 (fr)
BR (1) BR9911768A (fr)
CA (1) CA2336833C (fr)
CZ (1) CZ294087B6 (fr)
DE (2) DE19830201A1 (fr)
DK (1) DK1093369T3 (fr)
EA (1) EA003142B1 (fr)
EE (1) EE04296B1 (fr)
ES (1) ES2183583T3 (fr)
HU (1) HUP0103922A3 (fr)
ID (1) ID27776A (fr)
IL (1) IL140603A0 (fr)
MY (1) MY117969A (fr)
NO (1) NO20010064L (fr)
NZ (1) NZ509729A (fr)
PL (1) PL195043B1 (fr)
PT (1) PT1093369E (fr)
RS (1) RS49795B (fr)
SK (1) SK284923B6 (fr)
TR (1) TR200100146T2 (fr)
TW (1) TW592698B (fr)
WO (1) WO2000002542A2 (fr)
YU (1) YU401A (fr)
ZA (1) ZA200100090B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (fr) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Agents a effet antidepresseur, comprenant du pramipexol et un autre antidepresseur
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
AU2002360600B2 (en) * 2001-12-11 2007-11-29 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
JP2007518754A (ja) * 2004-01-22 2007-07-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング モノアミン神経伝達物質再取込みインヒビターとドーパミンアゴニストを含む医薬組成物
CA2619217A1 (fr) * 2005-08-15 2007-02-22 University Of Virginia Patent Foundation Neurorestauration avec du pramipexole r(+)
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
ES2379117T3 (es) 2006-05-16 2012-04-20 Knopp Neurosciences, Inc. Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
EP2137171A4 (fr) 2007-03-14 2010-05-19 Knopp Neurosciences Inc Synthèse de benzothiazole diamines substituées et purifiées du point de vue chiral
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
CA2734491A1 (fr) * 2008-08-19 2010-02-25 Knopp Neurosciences, Inc. Compositions et procedes employant du (r)-pramipexole
ES2459322T3 (es) 2008-09-05 2014-05-09 Supernus Pharmaceuticals, Inc. Método de tratamiento de trastorno de déficit de atención con hiperactividad (TDAH)
CA2760527A1 (fr) * 2009-04-30 2010-11-04 Supernus Pharmaceuticals, Inc. Procede de traitement d'une depression
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
CA2864088C (fr) 2012-02-08 2020-04-28 Supernus Pharmaceuticals, Inc. Formulations a liberation modifiee de viloxazine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
SMT202100119T1 (it) 2013-07-12 2021-05-07 Knopp Biosciences Llc Trattamento dei livelli elevati di eosinofili e/o basofili
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
US9763918B2 (en) 2013-08-13 2017-09-19 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
WO2015023786A1 (fr) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions et méthodes de traitement de troubles des cellules plasmatiques et de troubles prolymphocytaires à cellules b
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
ES3009607T3 (en) 2017-06-30 2025-03-27 Chase Therapeutics Corp Nk-1 antagonist compositions and methods for use in treating depression
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
EP0186087B1 (fr) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tétrahydro-benzothiazoles, leur procédé de préparation et leur utilisation comme intermédiaires ou médicaments
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
TR199801929T2 (xx) * 1996-03-29 1998-12-21 Pfizer Inc. Benzil(iden)-laktam t�revleri, bunlar�n 5-HT1A resept�rlerinin (ant)agonistler olarak kullan�mlar� .
CA2273809A1 (fr) * 1996-12-02 1998-06-11 Merck Sharp & Dohme Limited Utilisation d'antagonistes du recepteur nk-1 dans le traitement des diskynesies
CA2318095C (fr) * 1998-01-13 2012-11-20 Barry S. Fogel Methodes de traitement de la dyskinesie tardive et autres perturbations des mouvements

Also Published As

Publication number Publication date
ATE228365T1 (de) 2002-12-15
AU762128B2 (en) 2003-06-19
PL345842A1 (en) 2002-01-14
YU401A (sh) 2003-10-31
ES2183583T3 (es) 2003-03-16
HUP0103922A3 (en) 2002-08-28
NO20010064D0 (no) 2001-01-05
ID27776A (id) 2001-04-26
BR9911768A (pt) 2001-04-03
CZ200177A3 (en) 2001-06-13
TW592698B (en) 2004-06-21
RS49795B (sr) 2008-06-05
EE04296B1 (et) 2004-06-15
SK284923B6 (sk) 2006-02-02
HK1037976A1 (en) 2002-03-01
NZ509729A (en) 2003-06-30
EA200100084A1 (ru) 2001-08-27
SK112001A3 (en) 2001-10-08
HUP0103922A2 (hu) 2002-03-28
CN1230168C (zh) 2005-12-07
US6255329B1 (en) 2001-07-03
EA003142B1 (ru) 2003-02-27
BG105112A (bg) 2001-10-31
MY117969A (en) 2004-08-30
KR20010079491A (ko) 2001-08-22
TR200100146T2 (tr) 2001-07-23
KR100557692B1 (ko) 2006-03-07
IL140603A0 (en) 2002-02-10
CZ294087B6 (cs) 2004-10-13
PL195043B1 (pl) 2007-08-31
JP2002520273A (ja) 2002-07-09
ZA200100090B (en) 2002-04-04
AU5030399A (en) 2000-02-01
CA2336833A1 (fr) 2000-01-20
BG64972B1 (bg) 2006-11-30
CN1308533A (zh) 2001-08-15
DE19830201A1 (de) 2000-01-13
CA2336833C (fr) 2008-09-23
EP1093369B1 (fr) 2002-11-27
WO2000002542A2 (fr) 2000-01-20
DE59903556D1 (de) 2003-01-09
PT1093369E (pt) 2003-03-31
EP1093369A2 (fr) 2001-04-25
AR019896A1 (es) 2002-03-20
WO2000002542A3 (fr) 2000-06-22
EE200100014A (et) 2002-06-17
NO20010064L (no) 2001-03-02

Similar Documents

Publication Publication Date Title
DK1093369T3 (da) Middel med antidepressiv virkning indeholdende pramipexol og sertralin
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
DK0996444T3 (da) Behandling af diabetes med thiazolidindion og metformin
NO991151D0 (no) Forbindelse og anvendelse derav
NO20006062L (no) Innkapslede brytere, blandinger og fremgangsmåte for anvendelse derav
DK1224297T3 (da) Alzheimers sygdom -sekretase, APP-substrater derfor og anvendelser deraf
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DE69913128D1 (de) Teilweise blockverschachtelte cdma-kodierung und dekodierung
NO20010446D0 (no) Substituert anilidforbindelser og metoder
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
DE59905437D1 (de) Toner und/oder Toner-Mischungen
NO20003916L (no) Benzotiadiazoler og derivater
NO20005173L (no) Gen som koder for heliomicin og anvendelse derav
NO20013237D0 (no) 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater
NO20003601D0 (no) Nye naftyl-substituerte og anilid-substituerte sulfonamider
DE69904279D1 (de) Aromatisches Polycarbodiimid und Polycarbodiimidfolie
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO20021612L (no) Karbonylstressreduserende middel
DE60023918D1 (de) MODIFIZIERTE CDNA DES bcl-x GENS DER RATTE UND MODIFIZIERTES PROTEIN
DE60041158D1 (de) Fixier- und/oder Zwischenübertragungstrommel
PT1140994E (pt) Proteinas da superficie externa, suas genes e sua utilizacao
DK1102543T3 (da) Cariesbekæmpende mælkeprodukt og anvendelse deraf
SI1093369T1 (sl) Sredstvo z antidepresivnim učinkom, ki obsega pramipeksol in sertralin